

S110
25th European Congress of Psychiatry / European Psychiatry 41S (2017) S106–S169
Methods
Hundred and fifty amateur and/or professional musi-
cians who regularly take part in public performances (GM) and 150
subjects from the general population (GP) completed a task of facial
emotion recognition and were assessed in terms of accuracy and
reaction time. The group ofmusicianswas subdivided between sub-
jects with and without MPA indicators. Data were analyzed using
Student’s t test (
P
< 0.05) within the statistical package for the social
sciences.
Results
GM were less accurate and had a longer reaction time in
the recognition of facial happiness (
P
< 0.001, effect size: 0.25–0.44)
compared to GP. Musicians with MPA had a still lower accuracy in
the recognition of happiness, as well as longer reaction times for
emotions as a whole (
P
< 0.04; effect size: 0.32–0.40) compared to
musicians without MPA.
Conclusion
The poorer performance of musicians in the recog-
nition of happiness suggests difficulties to recognize indicators of
social approval, which may negatively affect performance through
increased anxiety and negative thoughts that can favor the onset
of MPA.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2017.01.1881EW0013
A single dose of oxytocin on music
performance anxiety: Results
involving a situation of simulated
performance
F.L. Osório
∗
, A.E. M. Barbar , M.F. Donadon , J.A.S. Crippa
Medical School of Ribeirão Preto - São Paulo University, Neuroscience
and Behaviour, Ribeirão Preto, Brazil
∗
Corresponding author.
Introduction
Music performance anxiety (MPA) is a persistent
and distressing experience that involves apprehension linked
with musical performance in public (individual or collective).
Anxious individuals concentrate their anxiety in situations that
involve social scrutiny, favoring distorted, dysfunctional, and neg-
ative interpretations of that situation followed by experiences of
physiological symptoms associated with the exposure. The most
commonly used substances in the pharmacological management
of MPA are beta-blockers and benzodiazepines. However, these
options are not fully efficient and cause relevant side effects that
interfere mainly with performance. Therefore, investigations on
alternative substances to treat MPA are highly opportune.
Objective
To assess the acute effects of oxytocin (OT) on physi-
ological and cognitive variables during an experimental model of
simulated performance.
Methods
We assessed 12 musicians with MPA pre-treated with
intranasal OT (24 UI) or placebo in a crossover trial involving an
experimental situation of public performance. Cognitive and phys-
iological measures (heart rate, blood pressure, salivary cortisol)
were recorded before/during performance (anticipatory perfor-
mance anxiety). Statistical analyses were made using Stata Direct.
Results
The results showed no effects of OT on physiological
symptoms (
P
> 0.190). In respect to anticipatory anxiety, however,
we found a tendency for OT to reduce negative cognitions asso-
ciated with music performance (
P
= 0.06). No side effects were
reported by musicians throughout the trial.
Conclusion
These tendencies, if confirmed through the expan-
sion of the sample, have important implications for the practice of
amateur and professional musicians who could benefit from inter-
ventions as the one described, possibly with a lesser impact of side
effects.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2017.01.1882EW0014
Music performance anxiety: Perceived
causes and coping strategies
F.L. Osório
1 ,∗
, A.B. Burin
1, I.S. Nirenberg
2, A.E.M. Barbar
11
Medical School of Ribeirão Preto, São Paulo University,
Neuroscience and Behaviour, Ribeirão Preto, Brazil
2
Rio de Janeiro Federal University, Music School, Rio de Janeiro, Brazil
∗
Corresponding author.
Introduction
The understanding of the causes of music perfor-
mance anxiety (MPA) and of strategies to cope with it is important
for the comprehension/management of this common condition in
musicians.
Objective
To investigate the causes of MPA reported by Brazilian
musicians and the efficacy of the most commonly used strategies
to cope with it.
Methods
Two hundred and fourteen Brazilian musicians (53%
professional/musicians from orchestras, 67% male, mean age:
34.02 years, 65% with over 11 years of education, 42% of which
played string instruments) completed different self-rating scales
to assess the presence/absence of MPA.
Results
Thirty-nine per cent of the musicians had indicators
of MPA. The most commonly reported causes were repertoire
difficulty (57%), concerns about audience response (52%), and self-
pressure (51%). The most common coping techniques included
breathing/relaxing techniques (66%) and increased practice (53%),
regarded as efficient by at least 49% of the musicians. Strategies
like seeing a doctor/psychiatrist/psychologist and taking antide-
pressant/anxiolytic medication were among the least frequently
used in the sample. Also, 18% of musicians with MPA used beta-
blockers and 6% used non-prescribed medications. Comparatively,
musicians with MPA believed that it was associated with a higher
number of conditions and regarded coping techniques as less effi-
cient.
Conclusion
Musicians consider internal situations to be the
most frequent causes of MPA and use different coping strate-
gies with average effectiveness. Results highlight the poor use of
well-established therapeutic resources and the occurrence of self-
medication in the sample, which together point to the need for
attention on the part of mental health professionals to this specific
group.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2017.01.1883EW0015
Pregabalin in somatoform disorders
D. Pavicevic
1 ,∗
, D. Popovic
2, N. Zivkovic
3, G. Djokic
41
Clinic for Mental Disorders “Dr Laza Lazarevic”, Intensive Care Unit,
Belgrade, Serbia
2
General Hospital “Petrovac na Mlavi”, Psychiatric Practice and
Consultative Service, Petrovac na Mlavi, Serbia
3
Clinic for Mental Disorders “Dr Laza Lazarevic”, Department for
acute psychosis, Belgrade, Serbia
4
Clinic for Mental Disorders “Dr Laza Lazarevic”, Assistant Director,
Neurology Consultation Service, Belgrade, Serbia
∗
Corresponding author.
Somatoform disorders (SD) are an example of the complex interac-
tion between mind and body.
To estimate the efficacy of pregabalin (PG) versus combination of
pregabalin and antidepressants in patients with SD who were pre-
viously on long-term treatment with at least three antidepressants
(SSRI, SNRI, SARIs, SNDIs, MAOI, TCAs) in an adequate therapeu-
tic dose and had a partial response on it. In this open label trial
investigators diagnosed 41 patients by standard clinical interview
as F 45.0 and F 45.4 according to ICD-10 criteria and divided them
in two groups: experimental (Pregabalin, 20 patients) and control